Compare NTRA & PKG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTRA | PKG |
|---|---|---|
| Founded | 2003 | 1867 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.0B | 17.4B |
| IPO Year | 2015 | 2000 |
| Metric | NTRA | PKG |
|---|---|---|
| Price | $230.24 | $204.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 7 |
| Target Price | $229.56 | ★ $233.43 |
| AVG Volume (30 Days) | ★ 1.5M | 740.8K |
| Earning Date | 11-06-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.44% |
| EPS Growth | N/A | ★ 15.38 |
| EPS | N/A | ★ 9.90 |
| Revenue | $2,116,676,000.00 | ★ $8,771,800,000.00 |
| Revenue This Year | $32.77 | $9.43 |
| Revenue Next Year | $16.51 | $13.27 |
| P/E Ratio | ★ N/A | $20.72 |
| Revenue Growth | ★ 38.17 | 7.30 |
| 52 Week Low | $125.38 | $172.72 |
| 52 Week High | $246.90 | $242.68 |
| Indicator | NTRA | PKG |
|---|---|---|
| Relative Strength Index (RSI) | 59.84 | 56.42 |
| Support Level | $233.67 | $193.01 |
| Resistance Level | $246.90 | $206.17 |
| Average True Range (ATR) | 6.70 | 4.70 |
| MACD | -2.14 | 1.02 |
| Stochastic Oscillator | 28.66 | 92.32 |
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Packaging Corp. of America is the third-largest containerboard and corrugated packaging manufacturer in the United States. It produces over 5 million tons of containerboard annually. The company's share of the domestic containerboard market is roughly 10%. PCA differentiates itself from larger competitors by focusing on smaller customers and operating with a high degree of flexibility.